Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...

Blood Flow

Blood Flow

Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Model Approaches for Pharmacokinetic Data: Physiological Models

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of Drugs for the Treatment of Multiple Sclerosis in Severe Acute Respiratory Syndrome Coronavirus 2 Infection on the Expression of Angiotensin-converting Enzyme 2 in vitro.

Current neuropharmacology·2026

Same author

Choroid plexus remodeling linked to impaired CSF-mediated clearance and Alzheimer's disease progression.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Endocytic turnover of endothelial cell-membrane proteins as a driver of rat blood-brain barrier specialization and dysfunction.

iScience·2026

Same author

Investigation of Magnesium Hydroxide as a Halogen-Free Fire-Retardant Filler for Advanced Polymer-Based Solutions: A Review.

Polymers·2026

Same author

Avidity-by-design: spatial control of T7 peptide presentation on polymersomes dictates blood-brain barrier transport fate.

Drug delivery and translational research·2026

Same author

A computational analysis of the glycoprotein LRP1 structure and the role of glycans as quaternary glue.

Bioinformatics (Oxford, England)·2026

Same journal

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Scientific reports·2026

Same journal

Effects of black soldier fly (Hermetia illucens L.) larvae zoocompost on the mineral element content of blue honeysuckle berries.

Scientific reports·2026

Same journal

Investigation on absorption refrigeration performance of R1243zf with imidazolium ionic liquid as the working pairs.

Scientific reports·2026

Same journal

DeepTriage-CN: integrating clinical text with vital signs for emergency department admission prediction in an aging population.

Scientific reports·2026

Same journal

Gold nanoparticles as dual-action antiviral agents: disruption of SARS-CoV-2 viral envelopes and RNA integrity.

Scientific reports·2026

Same journal

Comparison of capillary microsampling and venous blood for multi-pathogen serosurveillance.

Scientific reports·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 11, 2026

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach.

Gavin Fullstone¹, Jonathan Wood², Mike Holcombe³

¹1] Department of Chemistry, University College London, UK [2] MRC Centre for Molecular Virology, University College London, UK [3] Department of Computer Science, University of Sheffield, UK.

Scientific Reports

|June 11, 2015

Summary

This summary is machine-generated.

Red blood cells are crucial for distributing nanoparticles in capillaries. Nanoparticle size and population uniformity can improve tumor targeting and reduce off-target effects in drug delivery.

More Related Videos

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales

Published on: November 25, 2020

Taking Advantage of Reduced Droplet-surface Interaction to Optimize Transport of Bioanalytes in Digital Microfluidics

Taking Advantage of Reduced Droplet-surface Interaction to Optimize Transport of Bioanalytes in Digital Microfluidics

Published on: November 10, 2014

Related Experiment Videos

Last Updated: Apr 11, 2026

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales

Published on: November 25, 2020

Taking Advantage of Reduced Droplet-surface Interaction to Optimize Transport of Bioanalytes in Digital Microfluidics

Taking Advantage of Reduced Droplet-surface Interaction to Optimize Transport of Bioanalytes in Digital Microfluidics

Published on: November 10, 2014

Area of Science:

Biomedical Engineering
Nanotechnology
Computational Biology

Background:

Blood-mediated nanoparticle delivery is a key area for developing advanced therapeutics and diagnostics.
Nanoparticle properties (size, shape, surface chemistry) influence their behavior in biological systems, affecting immune interactions, clearance, and cellular uptake.
Effective nanoparticle delivery relies on their behavior within the bloodstream, particularly under capillary flow conditions.

Purpose of the Study:

To develop an agent-based model simulating nanoparticle behavior in capillary blood flow.
To investigate the role of red blood cells in nanoparticle distribution.
To explore how nanoparticle characteristics, such as size and polydispersity, can be optimized for targeted delivery, specifically to tumor tissues.

Main Methods:

An agent-based model was created to simulate nanoparticle dynamics within capillaries.
The model incorporated interactions between nanoparticles and red blood cells under blood flow conditions.
Simulations were performed to evaluate the impact of nanoparticle size and population polydispersity on tissue targeting.

Main Results:

Red blood cells significantly enhance nanoparticle distribution within capillaries.
Nanoparticle size can be manipulated to achieve selective targeting of tumor tissue over normal tissue.
The polydispersity of nanoparticle populations is a critical factor for optimizing specificity and minimizing off-target accumulation.

Conclusions:

Red blood cells play a vital role in the effective distribution of nanoparticles in the microvasculature.
Nanoparticle design, including precise control over size and polydispersity, is essential for targeted therapeutic delivery and minimizing side effects.
The developed model offers a valuable tool for predicting nanoparticle uptake and guiding future nanoparticle design for enhanced therapeutic efficacy.